Crisis Rocks Edo Sickle Cell Centre Over Alleged Administration Of Opioids Drugs On Patients


Posted on: Tue 07-02-2017

The Edo State Sickle Cell Board Chairman, Prof. (Mrs.) Caroline Edijana Omoti has called on the Edo State Governor, Godwin Obaseki, to urgently wade into the crisis brewing at the sickle cell centre following allegations of misconducts by some members of the board ranging from financial inducement and the alleged indiscriminate administration of opioids to patients at their detriment at the facility.
 
Omoti while calling on the governor to check the excesses and actions of some members of the board alleged that some members in the board in December, 2016 organised a protest at the Sickle Cell Centre to protest the removal of Dr. Peter O. Iyawe from service of the centre.
 
She said “During this protest, they made additional baseless claims that suggest that the Board was not running the centre properly. Dr. Iyawe was engaged by a previous Board as a casual staff. He is not a full staff of Edo State Government.”
 
Omoti alleged that following her investigation, that some board members were engaged in unethical practices and providing sickle cell patients opioids drugs that are considered dangerous to the health of patients, warned all those involved in the nefarious acts to desist.
 
She alleged that her decision to stop the use of opioids for patients did not go down well with those members allegedly sanctioned by her, hence, the call for her removal and wondered why some members of the Sickle cell association are in the habit of blackmailing the authorities and had held several public protests against the former Commissioner of Health and the Edo State Government.
 
Reacting to the allegations, members of the sickle cell club in a petition against the board chairman, Prof. (Mrs.) Omoti, signed by its president; Gregory Asekome Aigbonoga, howver alleged that the board chairman lacks empathy, respect and dignity towards sickle cell sufferers and their relatives in the centre, adding that, under her watch, drugs that were supposed to be administered to patients by donor agencies are either sold at exorbitant prices to sickle cell sufferers or let to expire completely.
 
By: Patrick Ochoga
Leadership News